CD8A and pancreatic neoplasm: The tumor infiltrating lymphocyte (TIL) population in pancreatic cancer shows clinical correlates that higher proportions of CD4+, CD8+ and dendritic cells (DCs) of TILs can improve the prognosis of affected patients with [19].